Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers Publisher



Taherianesfahani Z1 ; Abedindo A1 ; Nikpayam E1 ; Tasharofi B1 ; Nezamabadi AG2 ; Ghafourifard S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Cancer Management Published:2016


Abstract

Context: Ovarian cancer is the most fatal gynecological malignancy with no effective screening strategy for early detection. As most cases are being detected in advance stages, conventional therapies are not beneficial for the majority of patients. Cancer-testis antigens (CTAs) are a group of tumor associated antigens with specific expression pattern in cancers which potentiate them for application as cancer biomarkers and targets for immunotherapy. Evidence Acquisition: We performed a computerized search of the MEDLINE/PUBMED databases with key words: ovarian cancer, cancer-testis antigen, biomarker and immunotherapy. Results: Thirty five CTAs have been shown to be expressed in ovarian cancer. At least 13 of them have been shown to elicit immune responses in different studies. The pattern of expression for some of them may facilitate molecular classification of different histologic classes of ovarian cancer. In addition, some CTAs such as NY-ESO-1 and MAGE have been used as targets for immunotherapeutic approaches with promising results. Conclusions: The expression pattern of CTAs in ovarian cancer and the preliminary results of clinical trials indicate that CTAs can be used as targets for immunotherapy of ovarian cancer patients. © 2016, Iranian Journal of Cancer Prevention.
Related Docs
View other Related Docs
1. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers, Immunological Investigations (2016)
2. Tsga10, As a Cancer/Testis Gene: Review Article, Tehran University Medical Journal (2015)
3. An Introduction to Expression and Regulation of Testicular Cancer Antigens: Review Article, Tehran University Medical Journal (2018)
4. Upregulation of Rhoxf2 and Odf4 Expression in Breast Cancer Tissues, Cell Journal (2015)
5. Down-Regulation of Tsga10, Aurkc, Oip5 and Akap4 Genes by Lactobacillus Rhamnosus Gg and Lactobacillus Crispatus Sj-3C-Us Supernatants in Hela Cell Line; [Supernatanty Lactobacillus Rhamnosus Gg a Lactobacillus Crispatus Sj-3C-Us Snizuji Expresi Genu Tsga10, Aurkc, Oip5 a Akap4 V Hela Bunkach], Klinicka Onkologie (2018)
6. Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers Using Dysregulation of Piwi Protein and Pirnas As Biomarkers, Current Medicinal Chemistry (2024)
7. Tsga10 Expression Correlates With Sperm Profiles in the Adult Formalin-Exposed Mice, Andrologia (2016)
8. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
Experts (# of related papers)
View all Related Experts
Mohammad Hossein Modarressi (16)
Nima Rezaei (7)
Other Related Docs
9. Cancer/Testis Oip5 and Taf7l Genes Are Up-Regulated in Breast Cancer, Asian Pacific Journal of Cancer Prevention (2015)
10. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
11. Long Non-Coding Rna Ghet1 Is Possibly Involved in the Pathogenesis of a Fraction of Breast Cancers, International Journal of Cancer Management (2017)
12. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
13. Anti-Angiogenic Effects of Testis-Specific Gene Antigen 10 on Primary Endothelial Cells, Gene (2020)
14. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
15. Specific Immunotherapy in Ovarian Cancer: A Systematic Review, Immunotherapy (2016)
16. Urine Exosome Gene Expression of Cancer-Testis Antigens for Prediction of Bladder Carcinoma, Cancer Management and Research (2018)
17. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
18. Identification of New Tsga10 Transcript Variants in Human Testis With Conserved Regulatory Rna Elements in 5'Untranslated Region and Distinct Expression in Breast Cancer, Biochimica et Biophysica Acta - Gene Regulatory Mechanisms (2017)
19. Transcriptome Analysis of the Cancer/Testis Genes, Daz1, Aurkc, and Tex101, in Breast Tumors and Six Breast Cancer Cell Lines, Tumor Biology (2015)
20. Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer, Iranian Journal of Public Health (2017)
21. Expression Analysis of Tsga10 During in Vitro Differentiation of Germ Cells From Mouse Embryonic Stem Cell, Tehran University Medical Journal (2015)
22. Identification of Tsga10 and Ggnbp2 Splicing Variants in 5′ Untranslated Region With Distinct Expression Profiles in Brain Tumor Samples, Frontiers in Oncology (2023)
23. Cancer/Testis Genes in Relation to Sperm Biology and Function, Iranian Journal of Basic Medical Sciences (2017)
24. New Function of Tsga10 Gene in Angiogenesis and Tumor Metastasis: A Response to a Challengeable Paradox, Human Molecular Genetics (2016)
25. Prediction the Functional Impacts of Highly Deleterious Non-Synonymous Variants of Tsga10 Gene, Molecular Biology Research Communications (2025)
26. Tsga10 Overexpression Inhibits Angiogenesis of Huvecs: A Hif-2Α Biased Perspective, Microvascular Research (2020)
27. Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer, Iranian Journal of Public Health (2016)
28. Identification and Expression Analysis of Zebrafitestis-Specific Gene 10 (Tsga10), International Journal of Developmental Biology (2019)
29. Akap3 Correlates With Triple Negative Status and Disease Free Survival in Breast Cancer, BMC Cancer (2015)